Core Viewpoint - Medisi (688202.SH) experienced a significant decline of nearly 9%, reaching a new low of 56.14 yuan, with a total market value of 7.54 billion yuan due to a share reduction announcement by shareholder Chen Guoxing [1] Summary by Relevant Sections - **Share Reduction Announcement** - Shareholder Chen Guoxing plans to reduce holdings by no more than 2.2 million shares, representing up to 1.64% of the company's total share capital [1] - The company has issued share reduction plan announcements four times in the past three years [1] - **Financial Performance** - The company reported third-quarter revenue of 303 million yuan, reflecting a year-on-year growth of 7.94% [1] - The net profit showed a loss of 16.7865 million yuan [1]

Core Viewpoint - MediXis (688202) experienced a significant stock decline of over 8% following the announcement of a planned share reduction by a major shareholder [1] Group 1: Stock Performance - On November 20, MediXis's stock price dropped to 56.55 CNY per share, reflecting a decline of 8.27% [1] Group 2: Shareholder Actions - Shareholder Chen Guoxing intends to reduce his holdings by up to 2.2 million shares, which represents no more than 1.64% of the company's total share capital [1]

Policy Developments - The National Medical Products Administration (NMPA) is focusing on the quality supervision of selected drugs in centralized procurement, emphasizing the importance of quality safety and compliance in production [1] - The NMPA will implement comprehensive production inspections and product sampling for selected drugs, optimizing work mechanisms and exploring risk monitoring [1] - The NMPA acknowledges the development of the medical device industry in Chongqing and stresses the need for a robust quality safety responsibility system [2] Drug and Device Approvals - Baiyunshan's subsidiary Zhongyi Pharmaceutical received a registration certificate for the traditional medicine An Gong Niu Huang Wan from Vietnam's Ministry of Health, aiding market expansion [3] - Huyou Pharmaceutical announced that its subsidiary Seacross Pharmaceuticals Ltd. received marketing approvals for multiple products from regulatory authorities in Pakistan, the UK, and North Macedonia [4] - Zhifei Biological's recombinant herpes zoster vaccine (ZFA01) clinical trial application has been accepted by the NMPA, which may enhance vaccine efficacy [5] Capital Market Activities - Puluo Pharmaceutical plans to repurchase shares worth between RMB 180 million and RMB 360 million, with a maximum price of RMB 23 per share [6][7] - Sinovac Biotech received a delisting notice from NASDAQ due to failure to submit its annual report by the deadline, with potential trading suspension imminent [8] Industry Developments - Researchers published a detailed immune response map following pig kidney transplants in brain-dead patient models, identifying key factors for transplant success [9] - Haizheng Pharmaceutical's subsidiary plans to collaborate with the East China Institute for the biomanufacturing of heparin, with a project budget not exceeding RMB 120 million [10] Public Sentiment Alerts - Guangyuyuan announced the resignation of Vice President Wang Junbo due to work adjustments, effective immediately [11] - Medici's shareholder Chen Guoxing plans to reduce his stake by up to 1.64% through trading methods due to personal financial needs [12]

Core Viewpoint - The announcement details a share reduction plan by shareholder Chen Guoxing of Shanghai Medicy Bio-Pharmaceutical Co., Ltd., indicating a planned reduction of up to 2,200,000 shares, which is 1.64% of the total share capital, due to personal funding needs [3][11]. Shareholder Holdings - As of the announcement date, shareholder Chen Guoxing holds 4,875,154 shares, representing 3.63% of the total share capital, while together with his concert party Lin Changqing, they hold a total of 8,806,324 shares, accounting for 6.55% of the total share capital [2]. Reduction Plan Details - The reduction will be executed through centralized bidding and block trading within three months after the disclosure of the reduction plan, excluding periods when reductions are prohibited by regulations [3][6]. - The reduction price will be determined based on market prices at the time of the reduction, and adjustments will be made if there are changes in share capital due to dividends, stock splits, or other corporate actions [3][11]. Future Holding Intentions - After the completion of the reduction plan, Chen Guoxing intends to continue holding shares in the company and will comply with relevant laws and regulations regarding further reductions based on personal development needs [3][8]. Previous Commitments - Chen Guoxing has made commitments regarding shareholding, including a lock-up period of 36 months post-IPO, restrictions on transferring shares during certain conditions, and a maximum of 25% transfer of shares per year while serving as a director or senior management [7][8].

Key Points - 合富中国's stock will resume trading on November 20 after completing an investigation into unusual trading fluctuations, confirming normal business operations and no undisclosed significant matters [1] - 中金公司 plans to merge with 东兴证券 and 信达证券, leading to a suspension of its A-shares starting November 20 due to uncertainties surrounding the merger [1] - 大为股份 is progressing with the transition from exploration to mining rights for its lithium battery project in Hunan, having received necessary approvals [1] - 燕东微's major shareholders plan to reduce their stakes by up to 2.5% through block trades or centralized bidding from December 11, 2025, to March 11, 2026 [2] - 中水渔业's major shareholder reduced its stake to 5% after selling 258.88 million shares [3] - 韵达股份 reported a slight decline in express service revenue for October 2025, totaling 4.495 billion yuan, a year-on-year decrease of 0.88% [4] - 倍杰特 intends to acquire a 55% stake in 大豪矿业 for 224.8 million yuan [4] - 辰奕智能 plans to acquire a 55% stake in 华泽电子 through cash [4] - 赣粤高速's actual controller will change from the provincial transportation department to the provincial state-owned assets supervision and administration commission [5] - 东软集团 received a notification for a 4.2 billion yuan contract for intelligent cockpit controllers from a major domestic automotive manufacturer [5] - 海正药业's subsidiary plans to invest in a pet prescription food project [5] - 龙利得's controlling shareholder plans to increase its stake by at least 56 million yuan [6] - 新兴装备's shareholders plan to reduce their stakes by up to 3.13% [6] - 普洛药业 plans to repurchase shares worth between 180 million and 360 million yuan [6]

Core Viewpoint - MediX announced that shareholder Chen Guoxing intends to reduce his holdings by up to 2,200,000 shares, representing 1.64% of the total share capital, due to personal funding needs [2] Summary by Sections Shareholder Holdings - As of the announcement date, Chen Guoxing holds 4,875,154 shares, accounting for 3.63% of the total share capital [2] - Together with his concerted actor Lin Changqing, they hold a total of 8,806,324 shares, which is 6.55% of the total share capital [2] Reduction Plan - The reduction will be executed through centralized bidding and block trading methods [2] - The implementation period for the reduction plan is within three months after the disclosure of the reduction plan, excluding the period prohibited by the China Securities Regulatory Commission and the Shanghai Stock Exchange [2]

Group 1: Company Buybacks - Longlide plans to repurchase company shares for no less than 56 million yuan [2] - Hanshuo Technology has obtained a commitment letter for a stock repurchase loan from a financial institution [2] - Prolo Pharmaceutical intends to use between 180 million to 360 million yuan to buy back company shares [2] Group 2: Company Sell-offs - Suda Co., Ltd. plans to reduce its holdings by no more than 3% [2] - Hunan Baiyin intends to reduce its holdings by no more than 1.95% [2] - Zimi Co., Ltd. plans to reduce its holdings by no more than 1% [2] - Zhongshui Fishery's third-largest shareholder has reduced its holdings by 2.5888 million shares, bringing its stake down to 5% [2] - We Online's investors plan to collectively reduce their holdings by no more than 5.94% [2] - Renmin Tongtai's controlling shareholder plans to reduce its holdings by no more than 1% [2] - Yanshiwei's fourth and fifth largest shareholders plan to reduce their holdings by no more than 1.5% and 1% respectively [2] - Langke Intelligent's shareholders plan to reduce their holdings by no more than 1.68% [2] - Yingben Co., Ltd.'s director plans to reduce his holdings by no more than 0.03% [2] - Sunshine Power has completed the implementation of share reduction plans by some directors and senior management [2] - Dipu Technology's shareholder plans to reduce his holdings by no more than 1.55% [2] - MediWest's shareholder plans to reduce his holdings by no more than 1.64% [2] - Huahai Qingke's shareholder plans to reduce his holdings by no more than 1% [2] - Liyuan Technology's shareholder plans to reduce his holdings by no more than 2.0303% [2] - New Emerging Equipment's shareholders plan to collectively reduce their holdings by no more than 3.13% [2] - Jinqiao Information's director plans to reduce his holdings by no more than 0.0675% [2] - Kanglongda's shareholder plans to reduce his holdings by no more than 3% [2]

Core Viewpoint - Medisi (688202.SH) announced that shareholder Chen Guoxing plans to reduce his holdings by a total of no more than 2.2 million shares, which accounts for up to 1.64% of the company's total share capital due to personal funding needs [1] Summary by Category - **Shareholder Actions** - Shareholder Chen Guoxing intends to reduce his stake through centralized bidding and block trading [1] - The total number of shares to be reduced is capped at 2.2 million [1] - **Impact on Company** - The reduction represents a maximum of 1.64% of the total share capital of the company [1]

Core Viewpoint - The announcement from Meidisi (688202) indicates that shareholder Chen Guoxing plans to reduce his stake in the company due to personal financial needs, which may impact the stock's market performance [2]. Summary by Sections Shareholder Actions - Chen Guoxing intends to reduce his holdings by up to 2.2 million shares, representing no more than 1.64% of the company's total equity [2]. - Currently, Chen Guoxing holds 4.8752 million shares, accounting for 3.63% of the total shares outstanding [2]. - Together with his concerted party Lin Changqing, they hold a total of 8.8063 million shares, which is 6.55% of the total equity [2].

Group 1 - The core point of the article is that Meidisi (688202.SH) announced a share reduction plan by shareholder Chen Guoxing due to personal funding needs [1] - Chen Guoxing intends to reduce a total of up to 2.2 million shares, which represents no more than 1.64% of the company's total share capital [1]